Clinical impact of bendamustine exposure on lymphopenia risk after bendamustine and rituximab combination therapy for follicular lymphoma: a single-institute retrospective study

Satoshi Yamasaki; Takumi Matsushima; Mariko Minami; Masanori Kadowaki; Ken Takase; Hiromi Iwasaki

doi:10.1007/s00277-020-04388-6

Clinical impact of bendamustine exposure on lymphopenia risk after bendamustine and rituximab combination therapy for follicular lymphoma: a single-institute retrospective study

Satoshi Yamasaki, Takumi Matsushima, Mariko Minami, Masanori Kadowaki, Ken Takase, Hiromi Iwasaki

内科

研究成果: ジャーナルへの寄稿 › レター › 査読

3 被引用数 (Scopus)

本文言語	英語
ページ（範囲）	209-211
ページ数	3
ジャーナル	Annals of Hematology
巻	101
号	1
DOI	https://doi.org/10.1007/s00277-020-04388-6
出版ステータス	出版済み - 1月 2022

!!!All Science Journal Classification (ASJC) codes

血液学

文献へのアクセス

10.1007/s00277-020-04388-6

他のファイルとリンク

引用スタイル

Clinical impact of bendamustine exposure on lymphopenia risk after bendamustine and rituximab combination therapy for follicular lymphoma : a single-institute retrospective study. / Yamasaki, Satoshi; Matsushima, Takumi; Minami, Mariko その他.

In: Annals of Hematology, Vol. 101, No. 1, 01.2022, p. 209-211.

研究成果: ジャーナルへの寄稿 › レター › 査読

@article{18e65ad6ff1b4e29b4884d4f22216749,

title = "Clinical impact of bendamustine exposure on lymphopenia risk after bendamustine and rituximab combination therapy for follicular lymphoma: a single-institute retrospective study",

author = "Satoshi Yamasaki and Takumi Matsushima and Mariko Minami and Masanori Kadowaki and Ken Takase and Hiromi Iwasaki",

note = "Funding Information: We thank the patients and clinical staff for their participation in the study. We also acknowledge the Clinical Research Institute, Kyushu Medical Hospital, for editorial support. We thank Joe Barber Jr., PhD, from Edanz Group (https://en-author-services.edanz.com/ac ) for editing a draft of this manuscript.",

year = "2022",

month = jan,

doi = "10.1007/s00277-020-04388-6",

language = "English",

volume = "101",

pages = "209--211",

journal = "Annals of Hematology",

issn = "0939-5555",

publisher = "Springer Verlag",

number = "1",

}

TY - JOUR

T1 - Clinical impact of bendamustine exposure on lymphopenia risk after bendamustine and rituximab combination therapy for follicular lymphoma

T2 - a single-institute retrospective study

AU - Yamasaki, Satoshi

AU - Matsushima, Takumi

AU - Minami, Mariko

AU - Kadowaki, Masanori

AU - Takase, Ken

AU - Iwasaki, Hiromi

N1 - Funding Information: We thank the patients and clinical staff for their participation in the study. We also acknowledge the Clinical Research Institute, Kyushu Medical Hospital, for editorial support. We thank Joe Barber Jr., PhD, from Edanz Group (https://en-author-services.edanz.com/ac ) for editing a draft of this manuscript.

PY - 2022/1

Y1 - 2022/1

UR - http://www.scopus.com/inward/record.url?scp=85098565482&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85098565482&partnerID=8YFLogxK

U2 - 10.1007/s00277-020-04388-6

DO - 10.1007/s00277-020-04388-6

M3 - Letter

C2 - 33392703

AN - SCOPUS:85098565482

SN - 0939-5555

VL - 101

SP - 209

EP - 211

JO - Annals of Hematology

JF - Annals of Hematology

IS - 1

ER -